Day 2 plenary of ASCO Breakthrough. Building equity in cancer care: from policy to action. Great work by World Health Organization (WHO) Great conversation and Q&A. Much work to do! ASCO #ASCOBT24 Melvin LK CHUA Tingting Zhang Lillian Siu

Neoadjuvant therapy for locally NPC presented by Anthony Chan. ✅ T4+/N2-3 ✅ IO coming into the landscape ✅ Awaiting predictive biomarker #ASCOBT24 ASCO Melvin LK CHUA Tingting Zhang Yu Fujiwara, MD Hidehito HORINOUCHI Kate Clarke 💉💉💉💉💉🚴 Annie Wong 黃毅敏

Love the session title. ‘Fighting Cancer with Robots and Lasers’ Emerging techniques in surgery and RT to improve outcomes and reduce morbidity/mortality. ASCO #ASCOBT24 Melvin LK CHUA Lillian Siu Tingting Zhang Hidehito HORINOUCHI Yu Fujiwara, MD Annie Wong 黃毅敏

#ASCOBT24 This year’s program tries to be as inclusive as possible. Last but not least - a thorough discussion on #HealthEconomics in #CancerCare across health systems and between payers and practitioners ASCO Robin Zon, MD, FACP, FASCO

Important conversation about global disparities in cancer care accessibility. 📍62% with accesss to HER2 testing and trastuzumab 📍51% with access to EGFR testing and EGFR TKI Despite life-saving and availability of biosimilars and generics. ASCO #ASCOBT24 Melvin LK CHUA

In between the sessions, Yokohama is a stunning city to explore. It’s peaceful and charming :) Block your calendar for ASCO Breakthrough 2025 on 7 to 9 August 2025! #ASCOBT24 #ASCOBT25

Program Chair Melvin LK CHUA opening Day 3 of #ASCOBT24, with keynote Dr Shimon Sakaguchi dissecting Treg biology as a strategy of tumor immunity ASCO

Day 3 of ASCO Breakthrough 2024. Excellent keynote by Dr Shimon Sakaguchi. Shining light on potential of Tregs inhibition in addressing immune resistance. #ASCOBT24 ASCO Lillian Siu Melvin LK CHUA Kevin Chua Tingting Zhang Yu Fujiwara, MD Hidehito HORINOUCHI

In ASCO breakthrough 2024, I enjoyed the Q&A sessions as much as the main lectures. Appreciate the time and platform for audience to engage. ASCO #ASCOBT24 Melvin LK CHUA Lillian Siu Kevin Chua Yu Fujiwara, MD Hidehito HORINOUCHI Tingting Zhang

Best part of ASCO breakthrough 2024 - meet old friends and make new ones. Love this bunch of smart, genuine and fun people. A great platform to unite us. #ASCOBT24 #ASCOBT25 ASCO Melvin LK CHUA Kevin Chua Lillian Siu Daniel Tan Martin Stockler

The inspirational & transformative keynote sessions from #ASCOBT24 are now available to the public! Keynote topics cover how AI informs the learning health system, equity in cancer care, and targeting regulatory T cells (Tregs) in cancer. Watch here: brnw.ch/21wLMLT

Earlier this month #ASCOBT24 brought together top clinicians & investigators who are putting cutting-edge research into practice. Follow along w/ consultant clinical onc & past IDEA recipient David D. W. Lee. for a #DayInTheLife as he attends sessions & makes connections. #medonc

Awesome to be the host country for ESTRO meets Asia 2024. Honored to speak along Joseph Wee, Hai-Qiang Mai and Anne Lee! Grateful for the FARO Travel Grant Award for my proferred paper. ESTRO FARO_Asia Melvin LK CHUA Kevin Chua Hongcheng Zhu 祝鸿程 Faculty of Medicine, Universiti Malaya

🚨🔥The future of #ThoracicOncology is in GREAT hands! The final meeting of the 2024 IASLC #Academy with this OUTSTANDING group of #EarlyCareer #Physicians & #Researchers at #WCLC24. Honored to serve as academy co-chair with my amazing friend Christian Rolfo & GREAT faculty.

An amazing panel to discuss issues about early career investigators in IASLC. A great way to start WCLC 2024. #WCLC24 Karen Kelly Stephen V Liu, MD Narjust Florez, MD, FASCO

Thank you for joining us for Day 1 at #WCLC24! We have a fantastic program scheduled over the next few days. We look forward to see you tomorrow morning. #LCSM #IASLC50 #LungCancer